Venous Thromboembolism

Patients who underwent cancer surgery had an increased risk for venous thromboembolism for up to 1 year after the procedure, results from a retrospective study published in JAMA Network Open showed.

The first Friday in February is Wear Red Day. In support of increasing awareness of women’s heart health, Healio | Cardiology Today compiled a list of recent news and updates on women and CVD research.

A recent study found that maternal cannabis use was linked to adverse pregnancy outcomes related to placental function.

Use of NSAIDs significantly increased risk for venous thromboembolism when used concomitantly with hormonal contraception already associated with medium/high risk vs. low/no-risk, according to study results published in The BMJ.

Statin therapy could lower the odds of blood clot formation conferred by hormone therapy in perimenopausal women, according to a case-control study published in JAMA Network Open.

In a recent survey, 69% of women said their clinician asked them about their concerns regarding breast density, 64% said their clinician discussed future breast cancer risk and 61% had discussions about other breast cancer screening options.

Women with venous thromboembolism associated with pregnancy, the postpartum period or combined oral contraceptives who have finished primary short-term treatment may be considered for thrombophilia testing.

According to published results, cemented total hip arthroplasty was associated with increased rates of infection, aseptic loosening and aseptic revision compared with cementless fixation for patients with osteoarthritis.

Preeclampsia was associated with a significantly increased venous thromboembolism risk during pregnancy and beyond 6 weeks postpartum, according to an observational cohort study published in JAMA Network Open.

Women with a history of infertility who use assisted reproductive technologies may have increased risk for CVDs, such as preeclampsia, stroke and heart failure, according to a presenter.